{
  "cik": 1034842,
  "cik_padded": "0001034842",
  "entityName": "RIGEL PHARMACEUTICALS INC",
  "fiscal_years": [
    {
      "accn": "0001034842-26-000015",
      "filed": "2026-03-03",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 40580000.0,
        "eps_diluted": 19.48,
        "net_income": 367024000.0,
        "operating_cash_flow": 75655000.0,
        "operating_income": 125466000.0,
        "stockholders_equity": 391480000.0,
        "total_assets": 513594000.0,
        "total_liabilities": 122114000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.31192908960866456,
        "roa_avg2y": 1.0833537494281034,
        "roa_period_end": 0.7146189402524172,
        "roe_avg2y": 1.8594414947513476,
        "roe_period_end": 0.9375293757024624
      }
    },
    {
      "accn": "0001034842-26-000015",
      "filed": "2026-03-03",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 56746000.0,
        "eps_diluted": 0.99,
        "net_income": 17485000.0,
        "operating_cash_flow": 31471000.0,
        "operating_income": 24192000.0,
        "stockholders_equity": 3288000.0,
        "total_assets": 163976000.0,
        "total_liabilities": 160688000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "leverage": 48.87104622871046,
        "roa_avg2y": 0.12435944395645819,
        "roa_period_end": 0.10663145826218472,
        "roe_avg2y": -1.3791607509070831
      }
    },
    {
      "accn": "0001034842-26-000015",
      "filed": "2026-03-03",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 32786000.0,
        "eps_diluted": -1.44,
        "net_income": -25091000.0,
        "operating_cash_flow": -5743000.0,
        "operating_income": -20491000.0,
        "stockholders_equity": -28644000.0,
        "total_assets": 117225000.0,
        "total_liabilities": 145869000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.19952764170748774,
        "roa_period_end": -0.21404137342716997,
        "roe_avg2y": 1.1874585896829153
      }
    },
    {
      "accn": "0001034842-26-000015",
      "filed": "2026-03-03",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 24459000.0,
        "eps_diluted": -3.44,
        "net_income": -58573000.0,
        "operating_cash_flow": -73758000.0,
        "operating_income": -55550000.0,
        "stockholders_equity": -13616000.0,
        "total_assets": 134279000.0,
        "total_liabilities": 147895000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.38840610463285,
        "roa_period_end": -0.43620372507987104,
        "roe_avg2y": -6.990452321279389
      }
    },
    {
      "accn": "0001558370-25-002169",
      "filed": "2025-03-04",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 18890000.0,
        "eps_diluted": -0.11,
        "net_income": -17914000.0,
        "operating_cash_flow": 5878000.0,
        "operating_income": -12496000.0,
        "stockholders_equity": 30374000.0,
        "total_assets": 167328000.0,
        "total_liabilities": 136954000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 4.508922104431422,
        "roa_avg2y": -0.12901413725306618,
        "roa_period_end": -0.1070591891375024,
        "roe_avg2y": -0.5563354037267081,
        "roe_period_end": -0.5897807335220913
      }
    },
    {
      "accn": "0001558370-24-002475",
      "filed": "2024-03-05",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "cash": 30373000.0,
        "eps_diluted": -0.18,
        "net_income": -29744000.0,
        "operating_cash_flow": -52185000.0,
        "operating_income": -28973000.0,
        "stockholders_equity": 34026000.0,
        "total_assets": 110378000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.23062101904654833,
        "roa_period_end": -0.26947398938194206,
        "roe_avg2y": -0.6772236199496818,
        "roe_period_end": -0.8741550578969024
      }
    },
    {
      "accn": "0001558370-23-003035",
      "filed": "2023-03-07",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "cash": 22521000.0,
        "eps_diluted": -0.4,
        "net_income": -66894000.0,
        "operating_cash_flow": -41510000.0,
        "operating_income": -69091000.0,
        "stockholders_equity": 53815000.0,
        "total_assets": 147569000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.4666838752886514,
        "roa_period_end": -0.4533065887821968,
        "roe_avg2y": -0.8173154460816656,
        "roe_period_end": -1.2430363281612933
      }
    },
    {
      "accn": "0001558370-22-002551",
      "filed": "2022-03-01",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "cash": 76322000.0,
        "operating_cash_flow": -58826000.0,
        "operating_income": -72683000.0,
        "stockholders_equity": 109877000.0,
        "total_assets": 139109000.0
      },
      "period_end": "2018-12-31",
      "ratios": {}
    },
    {
      "accn": "0001558370-21-002254",
      "filed": "2021-03-02",
      "fiscal_year": 2017,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "cash": 38290000.0,
        "operating_cash_flow": -77557000.0,
        "operating_income": -79616000.0,
        "stockholders_equity": 100646000.0,
        "total_assets": 119111000.0
      },
      "period_end": "2017-12-31",
      "ratios": {}
    },
    {
      "accn": "0001558370-20-001624",
      "filed": "2020-02-27",
      "fiscal_year": 2016,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "cash": 17632000.0,
        "operating_cash_flow": -75889000.0,
        "operating_income": -69741000.0,
        "stockholders_equity": 55027000.0,
        "total_assets": 78134000.0
      },
      "period_end": "2016-12-31",
      "ratios": {}
    },
    {
      "accn": "0001047469-13-002185",
      "filed": "2013-03-05",
      "fiscal_year": 2012,
      "form": "10-K",
      "fundamental_units": {
        "eps_diluted": "USD/shares"
      },
      "fundamentals": {
        "eps_diluted": -1.32
      },
      "period_end": "2012-12-31",
      "ratios": {}
    },
    {
      "accn": "0001047469-13-002185",
      "filed": "2013-03-05",
      "fiscal_year": 2011,
      "form": "10-K",
      "fundamental_units": {
        "eps_diluted": "USD/shares"
      },
      "fundamentals": {
        "eps_diluted": -1.36
      },
      "period_end": "2011-12-31",
      "ratios": {}
    },
    {
      "accn": "0001047469-13-002185",
      "filed": "2013-03-05",
      "fiscal_year": 2010,
      "form": "10-K",
      "fundamental_units": {
        "eps_diluted": "USD/shares"
      },
      "fundamentals": {
        "eps_diluted": 0.72
      },
      "period_end": "2010-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001034842-26-000015",
    "filed": "2026-03-03",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001034842.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001034842.json"
  },
  "ticker": "RIGL"
}